Using Top-down and Bottom-up Costing Approaches in LMICs: The Case for Using Both to Assess the Incremental Costs of New Technologies at Scale

Estimating unbiased economies of scale of HIV prevention projects: A case study of Avahan

(2015) Aurélia Lépine et al.   SOCIAL SCIENCE & MEDICINE

Xpert MTB/RIF versus sputum microscopy as the initial diagnostic test for tuberculosis: a cluster-randomised trial embedded in South African roll-out of Xpert MTB/RIF

(2015) Gavin J Churchyard et al.   Lancet Global Health

Costing Hospital Surgery Services: The Method Matters

(2014) Gregoire Mercier et al.   PLoS One

Collecting and analysing cost data for complex public health trials: reflections on practice

(2014) Neha Batura et al.   Global Health Action

Step-by-step guideline for disease-specific costing studies in low- and middle-income countries: a mixed methodology

(2014) Marleen E. Hendriks et al.   Global Health Action

Tuberculosis Incidence Correlates with Sunshine: An Ecological 28-Year Time Series Study

(2013) Gavin C. K. W. Koh et al.   PLoS One

The Determinants of HIV Treatment Costs in Resource Limited Settings

(2012) Nicolas A. Menzies et al.   PLoS One

Population Health Impact and Cost-Effectiveness of Tuberculosis Diagnosis with Xpert MTB/RIF: A Dynamic Simulation and Economic Evaluation

(2012) Nicolas A. Menzies et al.   PLOS MEDICINE

Rapid Diagnosis of Tuberculosis with the Xpert MTB/RIF Assay in High Burden Countries: A Cost-Effectiveness Analysis

(2011) Anna Vassall et al.   PLOS MEDICINE

Commentary: Managing scaling up: what are the key issues?

(2010) L. Gilson et al.   HEALTH POLICY AND PLANNING

Health Economic Assessment: A Methodological Primer

(2009) Steven Simoens   International Journal of Environmental Research and Public Health

Equivalence of two healthcare costing methods: bottom-up and top-down

(2008) Michael K. Chapko et al.   HEALTH ECONOMICS